Abstract
Purpose
To describe the outcome of patients with Boston type 1 keratoprosthesis, with regard to anatomical and visual success.
Methods
Retrospective case series of patients who underwent Boston type I keratoprosthesis surgery at the Centro de Oftalmología Barraquer in Barcelona and at the University Eye Clinic in Salzburg between May 2006 and December 2011. Sixty-seven eyes were included. Anatomical success, visual acuity, and complication rate were evaluated and correlated with the initial diagnosis.
Results
The mean age of patients was 54 years; 62 % were male and 38 % were female. Eleven patients underwent Type I Boston Kpro implantation as a primary procedure, while the other 52 patients had previous graft failure. The most frequent diagnoses were autoimmune diseases (16 eyes), severe chemical or thermal burn (12 eyes), leukoma post-infectious keratitis (seven eyes) and bullous keratopathy (six eyes). The mean follow-up time was 26 months. Retention of the prosthesis was achieved in 95 % at 1 year and 78 % at 4.5 years. Two eyes suffered extrusion of the KPro, six underwent successful exchange of the prosthesis either due to infection, necrosis or extrusion, three KPro’s had to be explantated, and two eyes ended up in enucleation due to panophthalmitis. The outcome of the autoimmune cases was similar to the group with “other diagnoses” and better than those with chemical/thermal burn. The most frequent complication was development of a retroprosthetic membrane in 21 eyes (34 %). Visual acuity (LogMAR) in the chemical/thermal burn group was 2.30 preoperatively, 0.69 at 1 year, 0.52 at 2 years and 0.39 at 3 years; in the autoimmune group visual acuity was 2.3 preoperatively, 0.65 at 1 year, 0.15 at 2 years, and 1.5 at 3 years.
Conclusions
Boston type 1 keratoprosthesis is a viable option for patients with repeated graft failure, even for those with challenging diagnoses such as ocular burns and autoimmune syndromes.
Similar content being viewed by others
References
Colby KA, Koo EB (2011) Expanding indications for the Boston keratoprosthesis. Curr Opin Ophthalmol 22:267–273
de Araujo AL, Charoenrook V, De La Paz MF, Temprano J, Barraquer RI, Michael R (2012) The role of visual evoked potential and electroretinography in the preoperative assessment of osteo-keratoprosthesis or osteo-odonto-keratoprosthesis surgery. Acta Ophthalmol 90:519–525
Greiner MA, Li JY, Mannis MJ (2011) Longer-term vision outcomes and complications with the Boston Type 1 Keratoprosthesis at the University of California, Davis. Ophthalmology 118:1543–1550
Zerbe BL, Belin MW, Ciolino JB (2006) Results from the multicenter Boston Type 1 Keratoprosthesis Study. Ophthalmology 113:1779–7
Doane MG, Dohlman CH, Bearse G (1996) Fabrication of a keratoprosthesis. Cornea 15:179–184
Rudnisky CJ, Belin MW, Todani A, Al-Arfaj K, Ament JD, Zerbe BJ, Ciolino JB (2012) Risk factors for the development of retroprosthetic membranes with Boston keratoprosthesis type 1: multicenter study results. Ophthalmology 119:951–955
Durand ML, Dohlman CH (2009) Successful prevention of bacterial endophthalmitis in eyes with the Boston keratoprosthesis. Cornea 28:896–901
Chan CC, Holland EJ (2012) Infectious endophthalmitis after Boston type 1 keratoprosthesis implantation. Cornea 31:346–349
De La Paz MF, De Toledo JA, Charoenrook V, Sel S, Temprano J, Barraquer RI, Michael R (2011) Impact of clinical factors on the long-term functional and anatomic outcomes of osteo-odonto-keratoprosthesis and tibial bone keratoprosthesis. Am J Ophthalmol 151:829–839
De La Paz MF, de Alvarez TJ, Barraquer RI, Barraquer J (2008) Long-term visual prognosis of corneal and ocular surface surgery in patients with congenital aniridia. Acta Ophthalmol 86:735–740
Chodosh J, Dohlman C (2011) Indications for keratoprosthesis. In: Krachmer JH (ed) Cornea — surgery of the cornea and conjunctiva. Mosby Elsevier, London, pp 1689–1691
Schulze-Bonsel K, Feltgen N, Burau H, Hansen L, Bach M (2006) Visual acuities "hand motion" and "counting fingers" can be quantified with the Freiburg visual acuity test. Invest Ophthalmol Vis Sci 47:1236–1240
Chan CC, Holland EJ (2012) Infectious keratitis after Boston type 1 keratoprosthesis implantation. Cornea 31:1128–1134
Chew HF, Ayres BD, Hammersmith KM, Rapuano CJ, Laibson PR, Myers JS, Jin YP, Cohen EJ (2009) Boston keratoprosthesis outcomes and complications. Cornea 28:989–996
Patel AP, Wu EI, Ritterband DC, Seedor JA (2012) Boston type 1 keratoprosthesis: the New York Eye and Ear experience. Eye (Lond) 26:418–425
Yaghouti F, Nouri M, Abad JC, Power WJ, Doane MG, Dohlman CH (2001) Keratoprosthesis: preoperative prognostic categories. Cornea 20:19–23
Michael R, Charoenrook V, de la Paz MF, Hitzl W, Temprano J, Barraquer RI (2008) Long-term functional and anatomical results of osteo- and osteoodonto-keratoprosthesis. Graefes Arch Clin Exp Ophthalmol 246:1133–1137
Ciralsky J, Papaliodis GN, Foster CS, Dohlman CH, Chodosh J (2010) Keratoprosthesis in autoimmune disease. Ocul Immunol Inflamm 18:275–280
Kang JJ, de la Cruz J, Cortina MS (2012) Visual outcomes of Boston keratoprosthesis implantation as the primary penetrating corneal procedure. Cornea 31:1436–1440
Sayegh RR, Ang LP, Foster CS, Dohlman CH (2008) The Boston keratoprosthesis in Stevens–Johnson syndrome. Am J Ophthalmol 145:438–444
Magalhaes FP, Hirai FE, de Sousa LB, de Oliveira LA (2013) Boston type 1 keratoprosthesis outcomes in ocular burns. Acta Ophthalmol
Aldave AJ, Kamal KM, Vo RC, Yu F (2009) The Boston type I keratoprosthesis: improving outcomes and expanding indications. Ophthalmology 116:640–651
Sivaraman KR, Hou JH, Allemann N, de la Cruz J, Cortina MS (2013) Retroprosthetic membrane and risk of sterile keratolysis in patients with type I Boston keratoprosthesis. Am J Ophthalmol 155:814–822
Kamyar R, Weizer JS, de Paula FH, Stein JD, Moroi SE, John D, Musch DC, Mian SI (2012) Glaucoma associated with Boston type I keratoprosthesis. Cornea 31:134–139
Banitt M (2011) Evaluation and management of glaucoma after keratoprosthesis. Curr Opin Ophthalmol 22:133–136
Fintelmann RE, Maguire JI, Ho AC, Chew HF, Ayres BD (2009) Characteristics of endophthalmitis in patients with the Boston keratoprosthesis. Cornea 28:877–878
Goldman DR, Hubschman JP, Aldave AJ, Chiang A, Huang JS, Bourges JL, Schwartz SD (2013) Postoperative posterior segment complications in eyes treated with the Boston type I keratoprosthesis. Retina 33:532–541
Dokey A, Ramulu PY, Utine CA, Tzu JH, Eberhart CG, Shan S, Gelhbach PL, Akpek EK (2012) Chronic hypotony associated with the Boston type 1 keratoprosthesis. Am J Ophthalmol 154:266–271
Conflict of interest
There is no conflict of interest for any of the authors.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
de la Paz, M.F., Stoiber, J., de Rezende Couto Nascimento, V. et al. Anatomical survival and visual prognosis of Boston type I keratoprosthesis in challenging cases. Graefes Arch Clin Exp Ophthalmol 252, 83–90 (2014). https://doi.org/10.1007/s00417-013-2481-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-013-2481-6